List of works - Mauro Giuseppe Mastropasqua

A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer.

scientific article published on 13 May 2010

A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer

scientific article published on 29 June 2012

Accelerated partial breast irradiation with intraoperative electrons: using GEC-ESTRO recommendations as guidance for patient selection.

scientific article

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

scientific article

An international study to increase concordance in Ki67 scoring

scientific article published on 20 February 2015

Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.

scientific article published on 19 April 2015

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial

scientific article published on 11 March 2013

BETA-GALACTOSYLCERAMIDASE PROMOTES MELANOMA GROWTH VIA MODULATION OF CERAMIDE METABOLISM

scientific article published on 30 September 2020

Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy.

scientific article published on 19 November 2014

Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.

scientific article

Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

scientific article

Clinical and pathological assessment of high-risk ductal and lobular breast lesions: What surgeons must know

scientific article

Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single center study

scientific article published on 28 August 2020

Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution.

scientific article

Clinicopathological and immunohistochemical study of 30 cases of post-radiation atypical vascular lesion of the breast.

scientific article published on 19 June 2014

Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons

scientific article published on 4 May 2017

DCIS and LCIS are confusing and outdated terms. They should be abandoned in favor of ductal intraepithelial neoplasia (DIN) and lobular intraepithelial neoplasia (LIN).

scientific article published on 3 May 2013

Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies.

scientific article published in April 2003

Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer.

scientific article

HER2-negative (1+) breast cancer with unfavorable prognostic features: to FISH or not to FISH?

scientific article published on 12 March 2012

Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome.

scientific article published on 24 October 2012

High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy.

scientific article published on 15 June 2013

How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology

scientific article published on 13 January 2012

Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation.

scientific article published on 6 August 2011

Male breast cancer

scientific article published on 01 June 2010

Outcome and Medial Presentation of Breast Cancer: European Institute of Oncology Experience.

scientific article published on 10 July 2015

Paget's disease as a local recurrence after nipple-sparing mastectomy: clinical presentation, treatment, outcome, and risk factor analysis.

scientific article published on 10 February 2012

Positive axillary sentinel lymph node: is axillary dissection always necessary?

scientific article published on October 2011

Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

scientific article published on 29 January 2008

Primary Breast Extranodal Marginal Zone Lymphoma in Primary Sjögren Syndrome: Case Presentation and Relevant Literature

scientific article published on 10 December 2020

Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse.

scientific article

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer.

scientific article published on 23 March 2010

Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes

scientific article published on 31 March 2011

Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.

scientific article published on 12 March 2009

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole

scientific article

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

scientific article published on 6 August 2007

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

scientific article

Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.

scientific article published in November 2006

Risk of Locoregional Recurrence in Patients With False-Negative Frozen Section or Close Margins of Retroareolar Specimen in Nipple-Sparing Mastectomy

scientific article published on 21 July 2012

Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: preliminary report

scientific article published on 06 January 2006

Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression

scientific article published on 26 October 2013

What can the pathologist offer for optimal treatment choice?

scientific article published on October 2010

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial.

scientific article

[The stereotaxic core breast biopsy using the Mammotome: an alternative to intraoperative examination]

scientific article published on 01 August 2002

β3 adrenergic receptor as potential therapeutic target in ADPKD

scientific article published on 01 October 2021

List of works by Mauro Giuseppe Mastropasqua

A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer.

A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer

Accelerated partial breast irradiation with intraoperative electrons: using GEC-ESTRO recommendations as guidance for patient selection.

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

An international study to increase concordance in Ki67 scoring

Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial

BETA-GALACTOSYLCERAMIDASE PROMOTES MELANOMA GROWTH VIA MODULATION OF CERAMIDE METABOLISM

Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy.

Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.

Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

Clinical and pathological assessment of high-risk ductal and lobular breast lesions: What surgeons must know

Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single center study

Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution.

Clinicopathological and immunohistochemical study of 30 cases of post-radiation atypical vascular lesion of the breast.

Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons

DCIS and LCIS are confusing and outdated terms. They should be abandoned in favor of ductal intraepithelial neoplasia (DIN) and lobular intraepithelial neoplasia (LIN).

Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies.

Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer.

HER2-negative (1+) breast cancer with unfavorable prognostic features: to FISH or not to FISH?

Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome.

High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy.

How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology

Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation.

Male breast cancer

Outcome and Medial Presentation of Breast Cancer: European Institute of Oncology Experience.

Paget's disease as a local recurrence after nipple-sparing mastectomy: clinical presentation, treatment, outcome, and risk factor analysis.

Positive axillary sentinel lymph node: is axillary dissection always necessary?

Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

Primary Breast Extranodal Marginal Zone Lymphoma in Primary Sjögren Syndrome: Case Presentation and Relevant Literature

Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse.

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer.

Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes

Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.

Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.

Risk of Locoregional Recurrence in Patients With False-Negative Frozen Section or Close Margins of Retroareolar Specimen in Nipple-Sparing Mastectomy

Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: preliminary report

Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression

What can the pathologist offer for optimal treatment choice?

Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial.

[The stereotaxic core breast biopsy using the Mammotome: an alternative to intraoperative examination]

β3 adrenergic receptor as potential therapeutic target in ADPKD